[1]
2017. Helmet Continuous Positive Airways Pressure (CPAP) treatment in a Non-Small Cell Lung Cancer (NSCLC) patient with severe hypoxemic respiratory failure due to gemcitabine therapy. European Journal of Oncology and Environmental Health. 22, 1 (Jun. 2017), 43–46.